These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36700674)

  • 1. Distinguishing Brain Metastasis Progression From Radiation Effects After Stereotactic Radiosurgery Using Longitudinal GRASP Dynamic Contrast-Enhanced MRI.
    Berger A; Lee MD; Lotan E; Block KT; Fatterpekar G; Kondziolka D
    Neurosurgery; 2023 Mar; 92(3):497-506. PubMed ID: 36700674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging radiomics and machine learning to differentiate radiation necrosis from recurrence in patients with brain metastases.
    Basree MM; Li C; Um H; Bui AH; Liu M; Ahmed A; Tiwari P; McMillan AB; Baschnagel AM
    J Neurooncol; 2024 Jun; 168(2):307-316. PubMed ID: 38689115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.
    Sharma A; Mountjoy LJ; Butterfield RJ; Zhang N; Ross HJ; Schild SE; Sio TT; Daniels TB; Paripati HR; Mrugala MM; Vora SA; Patel NP; Zimmerman RS; Ashman JB; Porter AB
    Am J Clin Oncol; 2020 Feb; 43(2):128-132. PubMed ID: 31764021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases.
    Sharma M; Jia X; Ahluwalia M; Barnett GH; Vogelbaum MA; Chao ST; Suh JH; Murphy ES; Yu JS; Angelov L; Mohammadi AM
    Cancer Med; 2017 Sep; 6(9):2076-2086. PubMed ID: 28776956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical Exchange Saturation Transfer MRI for Differentiating Radiation Necrosis From Tumor Progression in Brain Metastasis-Application in a Clinical Setting.
    Mehrabian H; Chan RW; Sahgal A; Chen H; Theriault A; Lam WW; Myrehaug S; Tseng CL; Husain Z; Detsky J; Soliman H; Stanisz GJ
    J Magn Reson Imaging; 2023 Jun; 57(6):1713-1725. PubMed ID: 36219521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after stereotactic radiosurgery.
    Admojo L; Korte J; Anderson N; Phillips C; Caspersz L; Lasocki A
    J Med Imaging Radiat Oncol; 2023 Apr; 67(3):292-298. PubMed ID: 36650724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery of enlarging lesions after stereotactic radiosurgery for brain metastases in patients with non-small cell lung cancer with oncogenic driver mutations frequently reveals radiation necrosis: case series and review.
    Zhou F; Jiang L; Sun X; Wang Z; Feng J; Liu M; Ma Z
    APMIS; 2024 Jun; 132(6):375-381. PubMed ID: 38466886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis.
    Narloch JL; Farber SH; Sammons S; McSherry F; Herndon JE; Hoang JK; Yin FF; Sampson JH; Fecci PE; Blackwell KL; Kirkpatrick JP; Kim GJ
    Neuro Oncol; 2017 Oct; 19(10):1391-1397. PubMed ID: 28472527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium-Enhanced T2 FLAIR is an Imaging Biomarker of Radiation Necrosis and Tumor Progression in Patients with Brain Metastases.
    Heyn C; Bishop J; Moody AR; Kang T; Wong E; Howard P; Maralani P; Symons S; MacIntosh BJ; Keith J; Lim-Fat MJ; Perry J; Myrehaug S; Detsky J; Tseng CL; Chen H; Sahgal A; Soliman H
    AJNR Am J Neuroradiol; 2024 Nov; ():. PubMed ID: 39107039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery.
    Stockham AL; Tievsky AL; Koyfman SA; Reddy CA; Suh JH; Vogelbaum MA; Barnett GH; Chao ST
    J Neurooncol; 2012 Aug; 109(1):149-58. PubMed ID: 22638727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
    Miller JA; Bennett EE; Xiao R; Kotecha R; Chao ST; Vogelbaum MA; Barnett GH; Angelov L; Murphy ES; Yu JS; Ahluwalia MS; Suh JH; Mohammadi AM
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1060-1069. PubMed ID: 27742540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Liquid Biopsy to Assess Brain Tumor Recurrence: Presence of Circulating Mo-MDSC and CD14+ VNN2+ Myeloid Cells as Biomarkers That Distinguish Brain Metastasis From Radiation Necrosis Following Stereotactic Radiosurgery.
    Soler DC; Kerstetter-Fogle A; Elder T; Raghavan A; Barnholtz-Sloan JS; Cooper KD; McCormick TS; Sloan AE
    Neurosurgery; 2020 Dec; 88(1):E67-E72. PubMed ID: 32823285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor habitat analysis by magnetic resonance imaging distinguishes tumor progression from radiation necrosis in brain metastases after stereotactic radiosurgery.
    Lee DH; Park JE; Kim N; Park SY; Kim YH; Cho YH; Kim HS
    Eur Radiol; 2022 Jan; 32(1):497-507. PubMed ID: 34357451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
    Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Asher AL; Sumrall AL; Buchwald ZS; Curran WJ; Shu HG; Crocker I; Burri SH
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):459-467. PubMed ID: 28871997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
    Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DSC Perfusion MRI-Derived Fractional Tumor Burden and Relative CBV Differentiate Tumor Progression and Radiation Necrosis in Brain Metastases Treated with Stereotactic Radiosurgery.
    Kuo F; Ng NN; Nagpal S; Pollom EL; Soltys S; Hayden-Gephart M; Li G; Born DE; Iv M
    AJNR Am J Neuroradiol; 2022 May; 43(5):689-695. PubMed ID: 35483909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.
    Boothe D; Young R; Yamada Y; Prager A; Chan T; Beal K
    Neuro Oncol; 2013 Sep; 15(9):1257-63. PubMed ID: 23814264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer.
    Bowden G; Kano H; Caparosa E; Park SH; Niranjan A; Flickinger J; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):766-72. PubMed ID: 25658792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases.
    Sayan M; Şahin B; Mustafayev TZ; Kefelioğlu EŞS; Vergalasova I; Gupta A; Balmuk A; Güngör G; Ohri N; Weiner J; Karaarslan E; Özyar E; Atalar B
    Neurocirugia (Astur : Engl Ed); 2021; 32(6):261-267. PubMed ID: 34743823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.